ANTIBODY RECOGNITION OF THE TUMOR-SPECIFIC BCR-ABL JOINING REGION IN CHRONIC MYELOID-LEUKEMIA

被引：64
|
作者：
VANDENDEREN, J
HERMANS, A
MEEUWSEN, T
TROELSTRA, C
ZEGERS, N
BOERSMA, W
GROSVELD, G
VANEWIJK, W
机构：
[1] ERASMUS UNIV,DEPT IMMUNOL & GENET,3000 DR ROTTERDAM,NETHERLANDS
[2] TNO,MED BIOL LAB,RIJSWIJK,NETHERLANDS
来源：
JOURNAL OF EXPERIMENTAL MEDICINE | 1989年 / 169卷 / 01期
关键词：
D O I：
10.1084/jem.169.1.87
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：87 / 98
页数：12
相关论文
共 50 条
  • [41] Evaluation of BCR-ABL/ABL Ratio Increase That Corresponds to BCR-ABL Mutation In Chronic Myeloid Leukemia Patients Treated by Imatinib
    Tsaur, Grigory
    Ivanova, Anna
    Popov, Alexander
    Yakovleva, Yulia
    Riger, Tatyana
    Plekhanova, Olga
    Ivanets, Yulia
    Misyurin, Andrey
    Suchkova, Marina
    Shorikov, Egor
    Saveliev, Leonid
    Fechina, Larisa
    BLOOD, 2010, 116 (21) : 1402 - 1402
  • [42] ANTISENSE BCR-ABL OLIGOMERS CAUSE NONSPECIFIC INHIBITION OF CHRONIC MYELOID-LEUKEMIA CELL-LINES
    OBRIEN, SG
    KIRKLAND, MA
    MELO, JV
    RAO, MH
    DAVIDSON, RJ
    MCDONALD, C
    GOLDMAN, JM
    LEUKEMIA, 1994, 8 (12) : 2156 - 2162
  • [43] GENE-TARGETED SPECIFIC-INHIBITION OF CHRONIC MYELOID-LEUKEMIA CELL-GROWTH BY BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDES
    SKORSKI, T
    SZCZYLIK, C
    MALAGUARNERA, L
    CALABRETTA, B
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 1991, 29 (03): : 85 - &
  • [44] THE ABL-BCR FUSION GENE IS EXPRESSED IN CHRONIC MYELOID-LEUKEMIA
    MELO, JV
    GORDON, DE
    CROSS, NCP
    GOLDMAN, JM
    BLOOD, 1993, 81 (01) : 158 - 165
  • [45] The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemia
    El-Tanani, Mohamed
    Nsairat, Hamdi
    Matalka, Ismail I.
    Lee, Yin Fai
    Rizzo, Manfredi
    Aljabali, Alaa A.
    Mishra, Vijay
    Mishra, Yachana
    Hromic-Jahjefendic, Altijana
    Tambuwala, Murtaza M.
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 254
  • [46] THE USEFULNESS OF BCR ABL REARRANGEMENT IN THE DIAGNOSIS AND EVOLUTION OF CHRONIC MYELOID-LEUKEMIA
    GONZALEZ, FA
    VILLEGAS, A
    FERRO, MT
    SANROMAN, C
    SAEZ, I
    LOPEZ, M
    DELPOTRO, E
    ALVAREZ, A
    MARTINEZ, R
    MADIAVILLA, JD
    ESPINOS, D
    MEDICINA CLINICA, 1993, 101 (14): : 521 - 524
  • [47] Specific assessment of BCR-ABL transcript overexpression and imatinib resistance in chronic myeloid leukemia patients
    Bianchini, Michele
    De Brasi, Carlos
    Gargallo, Patricia
    Gonzalez, Mariana
    Bengio, Raquel
    Larripa, Irene
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (04) : 292 - 300
  • [48] Chronic myeloid leukemia with p210 BCR-ABL and monocytosis
    Dass, Jasmita
    Jain, Sonal
    Tyagi, Seema
    Sazawal, Sudha
    LEUKEMIA & LYMPHOMA, 2011, 52 (07) : 1380 - 1381
  • [49] Characteristics of BCR-ABL gene variants in patients of chronic myeloid leukemia
    Amin, Huma
    Ahmed, Suhaib
    OPEN MEDICINE, 2021, 16 (01): : 904 - 912
  • [50] Identification of natural inhibitors of Bcr-Abl for the treatment of chronic myeloid leukemia
    Parcha, Phanikrishna
    Sarvagalla, Sailu
    Madhuri, Bindu
    Pajaniradje, Sankar
    Baskaran, Vinitha
    Coumar, Mohane Selvaraj
    Rajasekaran, Baskaran
    CHEMICAL BIOLOGY & DRUG DESIGN, 2017, 90 (04) : 596 - 608
12345